Manmeet Ahluwalia
Hematology & Oncology · Miami, FLNPI 1760623557
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $93,138 of the $102,880 with a category attached, or 90.5%. 30 manufacturers reported payments, led by Bayer at 26.1% of the total. Reporting peaked in 2021 at $25,473 and has fallen 52.9% since, to $11,998 in 2025. Among hematology & oncology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $1094.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$27K
- Insightec,inc$17K
- AbbVie$12K
- Siemens Medical Solutions USA, Inc.$11K
- Incyte Corporation$8K
- Viewray Technologies Inc$6K
- plus $22K from 24 others
Across 200 payments — averaging $23,297 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$1.3M
- Merck$1M
- Incyte Corporation$564K
- Pfizer$421K
- Insightec,ltd$361K
- Seagen Inc.$289K
- plus $707K from 16 others
What the payments were for
- Consulting fees$93,13891%
- Speaking & faculty fees$3,4773%
- Travel & lodging$2,4322%
- Food & beverage$3,8334%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 16 | $26,885 |
| Insightec,inc | 10 | $17,092 |
| AbbVie | 10 | $11,859 |
| Siemens Medical Solutions USA, Inc. | 4 | $11,223 |
| Incyte Corporation | 3 | $7,568 |
| Viewray Technologies Inc | 4 | $5,800 |
| Recordati_rare_diseases_inc. | 1 | $4,410 |
| Novocure Inc. | 4 | $3,434 |
| GT Medical Technologies, Inc | 3 | $2,633 |
| GSK | 1 | $2,600 |
| Sumitomo Pharma America, Inc. | 1 | $2,560 |
| Janssen Global Services, LLC | 1 | $2,480 |
| Celularity Inc. | 5 | $1,867 |
| Pfizer | 7 | $908 |
| Brainlab, Inc. | 4 | $356 |
| Janssen Scientific Affairs, LLC | 2 | $219 |
| AstraZeneca | 2 | $128 |
| Blue Earth Diagnostics | 2 | $123 |
| Rigel Pharmaceuticals, Inc. | 1 | $103 |
| Array Biopharma Inc | 1 | $97 |
| Astrazeneca UK Limited | 1 | $88 |
| Seagen Inc. | 2 | $86 |
| Servier Pharmaceuticals LLC | 1 | $77 |
| Elekta, Inc. | 1 | $70 |
| Caris MPI, Inc. | 1 | $62 |
| Immunitybio, Inc. | 1 | $40 |
| Johnson & Johnson | 1 | $37 |
| Beone Medicines USA, Inc. | 2 | $35 |
| Illumina, Inc. | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$102,880 in reported general payments places this provider in the 90th percentile of 694 hematology & oncology providers in Florida.
Other hematology & oncology in Miami
- Steven FeinMiami$1M
- Srikanth NagallaMiami$639K
- Neil NagovskiMiami$530K
- Carl LandgrenMiami$517K
- Raja MudadMiami$422K
- George NahasMiami$364K
- Fernando de ZarragaMiami$333K
- Mikkael SekeresMiami$278K
- Krishna KomanduriMiami$187K
- Estelamari RodriguezMiami$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.